Atelerix Launches BloodReady™: A Breakthrough in Whole Blood Preservation
Newcastle, UK – [17.02.2025] – Atelerix, the pioneering biotech company revolutionising cell preservation, has unveiled BloodReady™, a first-of-its-kind solution that
Newcastle, UK – [17.02.2025] – Atelerix, the pioneering biotech company revolutionising cell preservation, has unveiled BloodReady™, a first-of-its-kind solution that
By Rachel Sanders Preserving cell functionality during storage and transportation is challenging for cell-based therapies as cryopreservation methods can compromise
By Rachel Sanders In scientific research, efficiency and reliability are of the utmost importance, and one of the most persistent
By Sarah Marsh In an era where environmental consciousness is paramount, the scientific community faces a unique challenge: balancing
The biotech’s technology can transport cells in a more economically viable, higher performing and sustainable way Newcastle, UK –
By Rachel Sanders In multi-site clinical trials, cell preservation and transportation is a significant bottleneck. Coordinating shipments across multiple
By Sarah Marsh The transport of biological samples from patient to laboratory presents critical challenges, as the preservation of sample
By Sarah Marsh Effective financial expenditure is crucial for driving the pace of scientific research and maximising innovation. When it
By Sarah Marsh One of the biggest challenges faced by basic, pre-clinical, and clinical research is ensuring that the quality
CAMBRIDGE and NEWCASTLE, UK, 03 June 2024: DefiniGEN Ltd., and Atelerix Ltd., today announced they have successfully shipped in
In the pursuit of ground-breaking discoveries and life-changing innovations, the scientific community has long relied on a crucial yet often
Crafting a Future Beyond Cryopreservation – One Hedgehog at a Time Newcastle, UK – Wednesday 26th June 2024 – Atelerix, the